The process of freezing and storing sperm for future use is known as sperm banking. Sperm banking is frequently used for men who want to have children after undergoing infertility-causing treatment, such as certain cancer treatments. Sperm banking, also known as sperm cryopreservation, is a type of fertility preservation.

The Takeaway:

Big calls for sperm banking for infertility patients

Infertility is a disease of the male or female reproductive system defined by the failure to achieve pregnancy after 12 months or more of regular unprotected sexual intercourse. According to World Health Organization (WHO) statistics, infertility affects millions of people of reproductive age worldwide and has ramifications for their families and communities. According to estimates, 48 million couples and 186 million individuals worldwide suffer from infertility. Sperm freezing is the most effective method of preserving a man's fertility so that he can have children later in life. Men can freeze their sperm to use in future treatments or to donate to someone else's treatment. Before it can be used by a recipient, donated sperm is usually quarantined for three to six months and screened for infections.

Market Drivers

Sperm banking has gained significant attention in the global market for cancer patients

Some cancer treatments may have an impact on your fertility. Sperm banking is a method of storing donor sperm for later use in fertility treatment. According to the National Institute for Health and Care Excellence (NICE), doctors should offer sperm banking to any man undergoing cancer treatment that may affect his fertility. Teenage boys who have completed puberty can collect and store sperm as well. Sperm banking is free on the NHS in some parts of the United Kingdom. The National Institute for Health and Care Excellence (NICE) recommends that men who may become infertile as a result of cancer treatment have access to sperm storage.

High government involvement bolsters the growth of global sperm banking market

According to a report published in Canada, donor sperm for assisted reproduction is classified as a drug. It is governed by the Food and Drugs Act as well as the Semen Regulations. Section 23 of the Food and Drugs Act empowers Health Canada to inspect sperm establishments. In addition, the Assisted Reproductive Technology Act of 2007 (ART Act), which governs many ethical and social aspects of assisted reproductive technology, went into effect in 2010. The ART Act seeks to accomplish these goals by requiring ART providers to be registered with the NSW Ministry of Health and by establishing core standards for the provision of ART treatment. Furthermore, the ART Act and Regulation established the Central Register to store information about donors and children conceived after January 1, 2010 as a result of ART treatment using donated gametes (sperm and ova). Fertility treatments are covered by the NHS in some areas of the United Kingdom. If a woman is 39 or younger, the National Institute for Health and Care Excellence recommends that a couple be able to have three full cycles of in vitro fertilization (IVF) or ICSI if cancer treatment makes it unlikely that they will be able to have a baby naturally. If the woman is between the ages of 40 and 42 and has never had IVF, NICE recommends that one cycle be provided for free. However, this advice is not followed in all parts of the UK. The Infertility Network UK provides detailed information about NHS funding in the United Kingdom.

Market Opportunities

Sperm Banking has 100% gains in in-vitro fertilization (IVF) and surrogacy treatment

The Surrogacy Act of 2010 establishes a framework for the Supreme Court to issue orders transferring full legal parentage of children from their birth parent/s to the intended parent/s in the context of a surrogacy arrangement. The legislation specifies the requirements for reporting children born through surrogacy, as well as the issuance of parentage orders. Before the NSW Supreme Court can make a parentage order, intended parents must register information about themselves, their child, and the surrogate, as well as anyone who donated eggs, sperm, or embryos, with the Central Register.

The success rates listed below are from the Human Fertilization and Embryology Society and include healthy people undergoing treatment with insemination and IVF. Under the age of 35, the success rate is approximately 25 births per 100 treatments (25%) 35 to 39 years old out of 100 treatments, the success rate ranges between 15 and 20 births (15 to 20%) The success rate for women aged 40 to 42 is between 10 and 15 births per 100 treatments (10 to 15%).

Market Segmentation

The global sperm banking market is segmented based on donor type, service type, and end-user type. The donor type segment is classified into known donor and anonymous donor. By service type, the market is segregated as sperm storage, semen analysis, and genetic consultation. By end-user, the market is bifurcated into donor insemination and in vitro fertilization.

Regional Overview

North America holds the dominant share; Asia Pacific records lucrative growth for sperm banking market

In the sperm bank market, North America has the largest market share. This is due to an increase in the number of cases of infertility. In terms of market share, the United States leads North America, followed by Canada. According to the US Department of Health and Human Services, more than 6 million women between the age of 15 and 44 had difficulty conceiving or maintaining pregnancy in 2019. Furthermore, advancements in cryopreservation technology may help the market grow even more during the forecast period.

The Asia Pacific sperm banking market has the fastest growing CAGR. This is primarily due to the large male population suffering from infertility and the availability of low-cost fertility treatments. Furthermore, despite popular belief, an increase in the number of sperm donors is expected to drive market growth. Furthermore, rising awareness of the availability of fertility treatment options such as IVF and ICSI, as well as supportive government policies for sperm donations, contribute to the growth of the sperm bank market.

Competitive Landscape

The prominent players of the global sperm banking market involve Fairfax Cryobank, Inc., Xytex Corporation, Andocryos, Cryo-Save AG, New England Cryogenic Center, Seattle Sperm Bank, London Sperm Bank, and among others

Market Segmentation

Market By Donor Type

Known Donor
Anonymous Donor

Market By Services Type

Sperm Storage
Semen Analysis
Genetic Consultation

Market By End-Use Type

Donor Insemination
In vitro Fertilization

Market By Geography

North America
•    U.S.
•    Canada

Europe
•    U.K.
•    Germany
•    France
•    Spain
•    Rest of Europe

Asia-Pacific
•    China
•    Japan
•    India
•    Australia
•    South Korea
•    Rest of Asia-Pacific

Latin America
•    Brazil 
•    Mexico
•    Rest of Latin America

Middle East & Africa
•    GCC
•    South Africa
•    Rest of Middle East & Africa